Skip to main content
Clinical Trials/NCT04043962
NCT04043962
Completed
Not Applicable

Mechanisms Of Change in Adolescent Pain Self-management

Seattle Children's Hospital1 site in 1 country85 target enrollmentNovember 26, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
Seattle Children's Hospital
Enrollment
85
Locations
1
Primary Endpoint
Pain Intensity Ratings
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The MOCAS Study aims to describe the mechanisms through which sleep deficiency affects youth responses to an online pain self-management intervention over a 6-month period. The study is a single arm trial with repeated measurements using surveys, daily diaries, and actigraphic monitoring.

Detailed Description

The study objective is to characterize how sleep deficiency influences youth's ability to engage with, implement, and benefit from pain self-management intervention. The investigators will recruit a cohort of 80 youth, ages 12 to 17 years, with chronic musculoskeletal, head, or abdominal pain into a single arm trial conducted at one site. Assessments will occur at baseline, immediately after intervention, and repeated at 3 months post-intervention. Mediators will be assessed at mid-treatment (4 weeks). All youth will receive an 8-week internet-delivered pain self-management intervention (WebMAP). Following the recommended Common Data Elements for self-management three self-management processes are measured including patient activation, pain self-efficacy, and self-management skills, and patient-reported outcomes of health (global health, fatigue) and pain (pain symptoms, pain-related disability). Positive and negative affect and executive function are assessed as potential mediators. Sleep deficiency is comprehensively assessed with subjective measures, daily sleep logs, and ambulatory actigraphy monitoring to measure disrupted sleep, amount of sleep, sleep quality, and insomnia symptoms.

Registry
clinicaltrials.gov
Start Date
November 26, 2018
End Date
October 31, 2020
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Tonya Palermo

Professor, Anesthesiology and Pain Medicine

Seattle Children's Hospital

Eligibility Criteria

Inclusion Criteria

  • 12-17 years old
  • Has chronic pain (for at least 3 months)
  • Has internet access/email address

Exclusion Criteria

  • Diagnosis of a serious, comorbid health condition (e.g. cancer, arthritis, cystic fibrosis, lupus, etc.)
  • Parent/adolescent doesn't speak English
  • Active psychosis/suicidal ideation
  • Currently taking stimulating medications
  • Diagnosed sleep disorder (sleep apnea or narcolepsy)
  • Severe cognitive impairment/unable to read at 5th grade level or complete surveys independently

Outcomes

Primary Outcomes

Pain Intensity Ratings

Time Frame: Baseline, 12 weeks (post-treatment), 6 months (follow-up)

Pain intensity will be measured using the 11-point Numerical Rating Scale (NRS) completed by children via daily diary assessments over a 7-day period. Scores range from 0 = no pain to 10 = worst pain imaginable. Scores are averaged at each timeframe with higher scores indicating higher pain intensity.

Pain-related Disability

Time Frame: Baseline, 12 weeks (post-treatment), 6 months (follow-up)

The Child Activity Limitations Interview (CALI-9) is a daily diary validated to assess perceived difficulty in completing 9 daily activities as a measure of pain-related disability. Responses are rated on a 5-point scale (0-4), summed, and transformed to a 0-100 scale, with higher scores indicating greater perceived difficulty with activities. Youth will provide ratings daily for 7 days on their online diaries at each assessment period. Mean total activity limitations across the reporting period is used in analyses, with higher scores indicating greater disability.

Secondary Outcomes

  • Fatigue(Baseline, 12 weeks (post-treatment), 6 months (follow-up))
  • Global Health(Baseline, 12 weeks (post-treatment), 6 months (follow-up))
  • Number of Treatment Modules Completed(12 weeks (post-treatment))
  • Treatment Acceptability(12 weeks (post-treatment))

Study Sites (1)

Loading locations...

Similar Trials